Sensorion Announces Publication of SENS-401 Data in Otology & Neurology Journal. pdfRead

Sensorion announces positive topline results from Seliforant Phase 2a study. pdfRead

Sensorion announces a publication in Hearing Research on kinetics of prestin blood levels after noise trauma-induced hearing loss. pdfRead

Sensorion announces completion of patient enrollment and dosing in Seliforant phase 2a study. pdfRead

Sensorion enters into exclusive negotiations with Pasteur Institute for hearing loss Gene Therapy programs. pdfRead

Next events